Mendel Capital Management LLC Novavax Inc Transaction History

Mendel Capital Management LLC

  • $162 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
BUY
$8.86 - $25.04 $9,081 - $25,666
1,025 Added 4.3%
24,860 $0
Q2 2022

Jul 26, 2022
BUY
$36.28 - $75.29 $368,096 - $763,892
10,146 Added 74.12%
23,835 $1.23 Million
Q1 2022

May 02, 2022
BUY
$69.73 - $142.9 $214,419 - $439,417
3,075 Added 28.97%
13,689 $1.01 Million
Q4 2021

Feb 16, 2022
BUY
$134.56 - $217.97 $1.43 Million - $2.31 Million
10,614 New
10,614 $1.52 Million

Others Institutions Holding NVAX

# of Institutions
292
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Mendel Capital Management LLC Portfolio

Follow Mendel Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email